Furthermore, for all analysed PD-1 and PD-L1 markers, regardless of the lymphocyte subset, we observed a tendency to increase from the control group (lowest percentage) to the ICU group (highest percentage), indicating immune wasting in severely ill patients with COVID-19 (Table 2). Here, PDCD1 is linked to COVID-19.